Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

DSGNDSGN
11 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in DESIGN THERAPEUTICS INC

TUDOR INVESTMENT CORP ET AL previously held 0 shares of DSGN (DESIGN THERAPEUTICS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$181,000

Total Shares Change

-12,900

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$6.17
0
2024-Q3
Decreased
18,738
-5.7%
$100,8100.0%$5.33
0
2024-Q2
Decreased
19,865
-21.6%
$66,5480.0%$3.35
0
2024-Q1
New
25,327
-
$102,0680.0%$4.03
30
2023-Q4
Exited
0
-100.0%
$00.0%$2.65
0
2023-Q3
Decreased
16,299
-20.7%
$38,4660.0%$2.36
0
2023-Q2
Decreased
20,561
-25.6%
$129,5340.0%$5.82
0
2023-Q1
Increased
27,639
+56.3%
$159,0000.0%$5.70
32
2022-Q4
Decreased
17,684
-36.5%
$181,0000.0%$10.26
0
2022-Q3
Increased
27,866
+116.0%
$466,0000.0%$16.79
39
2022-Q2
New
12,900
-
$181,0000.0%$14.02
31

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used